US2013195975A1PendingUtilityA1

In vivo use of water absorbent polymers

Assignee: SIMON JAIMEPriority: Nov 20, 2000Filed: Aug 20, 2012Published: Aug 1, 2013
Est. expiryNov 20, 2020(expired)· nominal 20-yr term from priority
A61K 9/00A61K 31/78A61K 9/1635A61K 9/5073A61K 31/715A61K 31/716A61K 31/74A61K 47/32
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The subject invention is a method and material for removing fluid from the intestinal tract of a host and may be useful in treating animals or human patients suffering from fluid overload states. In one embodiment, the subject method involves ingesting an enterically coated non-systemic, non-toxic, non-digestible, water absorbing polymer which absorbs fluid while passing through the intestinal tract. The polymer is excreted in the feces wherein the polymer and absorbed fluid is removed from the body. Preferred polymers include super absorbent acrylic acid polymers, preferably provided in bead form. The polymers may include functional groups for selectively removing blood borne waste products, e.g. urea, from the G.I. tract.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for removing fluid from the intestinal tract of a host by directly delivering an effective amount of water-absorbent polymer to the intestinal tract. 
     
     
         2 . The method of  claim 1 , wherein the polymer is enterically coated and the method of delivery is oral administration. 
     
     
         3 . The method of  claim 1 , wherein the polymer is capable of absorbing at least about 10 times its weight in physiological saline. 
     
     
         4 . The method of  claim 3 , wherein the polymer is capable of absorbing at least 20 times its weight in physiological saline. 
     
     
         5 . The method of  claim 4 , wherein the polymer is capable of absorbing at least 30 times its weight in physiological saline. 
     
     
         6 . The method of  claim 5 , wherein the polymer is capable of absorbing at least 40 times its weight in physiological saline. 
     
     
         7 . The method of  claim 1 , wherein the polymer is formed by polymerizing acrylate containing monomers. 
     
     
         8 . The method of  claim 1 , wherein the polymer is formed by polymerizing monomer comprising acrylic acid or salts thereof. 
     
     
         9 . The method of  claim 1 , wherein the polymer is a polysaccharide. 
     
     
         10 . The method of  claim 1 , wherein the polymer includes functional groups for selectively absorbing blood borne waste products. 
     
     
         11 . The method of  claim 10 , wherein the polymer includes functional groups for selectively absorbing urea. 
     
     
         12 . The method of  claim 10 , wherein the polymer includes functional groups for selectively absorbing phosphate. 
     
     
         13 . The method of  claim 2 , wherein the enteric coating is selected from at least one of: hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, methacrylic acid polymers, or polymers of derivatives of methacrylic acid. 
     
     
         14 . The method of  claim 2 , wherein the polymer is placed within an enterically coated capsule. 
     
     
         15 . The method of  claim 14 , wherein the enteric coating is selected from at least one of: hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, methacrylic acid polymers, or polymers of derivatives of methacrylic acid. 
     
     
         16 . A method for treating fluid overload states in a host by directly delivering an effective amount of a water-absorbent polymer to the intestinal tract. 
     
     
         17 . The method of  claim 16 , wherein the polymer is enterically coated and the method of delivery is oral administration. 
     
     
         18 . The method of  claim 16 , wherein the fluid overload state is selected from at least one of: edema, congestive heart failure, ascites, and renal insufficiency. 
     
     
         19 . A composition for removing fluid from the intestinal tract of a host comprising an enterically coated, non-systemic, non-toxic, water-absorbing polymer capable of absorbing at least 10 times its weight in physiological saline. 
     
     
         20 . The composition of  claim 19 , wherein the polymer is capable of absorbing at least 20 times its weight in physiological saline. 
     
     
         21 . The composition of  claim 20 , wherein the polymer is capable of absorbing at least 30 times its weight in physiological saline. 
     
     
         22 . The composition of  claim 21 , wherein the polymer is capable of absorbing at least 40 times its weight in physiological saline. 
     
     
         23 . The composition of  claim 19 , wherein the polymer is formed by polymerizing acrylate containing monomers. 
     
     
         24 . The composition of  claim 19 , wherein the polymer is formed by polymerizing monomer comprising acrylic acid or salts thereof. 
     
     
         25 . The composition of  claim 19 , wherein the polymer is a polysaccharide. 
     
     
         26 . The composition of  claim 19 , wherein the polymer is a crosslinked polyally amine. 
     
     
         27 . The composition of  claim 19 , wherein the polymer is provided in bead form.

Join the waitlist — get patent alerts

Track US2013195975A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.